Key result
Transcatheter non-aortic valve therapies offer viable alternatives in high-risk patients, with roles still evolving.
Why the study?
To offer an up-to-date analysis of the rapidly expanding field of percutaneous technologies for mitral, tricuspid, and pulmonary valve procedures.
Transcatheter mitral, tricuspid, and pulmonary procedures are emerging as promising less-invasive alternatives for high-risk patients, though further advancements and data are needed to establish their definitive clinical roles.
May offer less-invasive options for high-risk valvular patients; leaves open their definitive role pending further randomized data.
The emergence of percutaneous treatment options provides novel therapeutic alternatives for older and feeble patients who are at high risk for any surgical procedure. The purpose of our review was to offer an up-to-date analysis of the rapidly expanding field of percutaneous technologies for mitral, tricuspid, and pulmonary procedures. Edge-to-edge repair is an established treatment for secondary mitral regurgitation (MR), while transcatheter mitral valve replacement is a potential and expanding option for managing both secondary and primary MR. However, additional advancements are necessary to enhance the safety and feasibility of this procedure. Transcatheter tricuspid intervention is an emerging option that was conceived after the success of transcatheter procedures in aortic and mitral valves, and it is currently still in the early stages of advancement. This can be attributed, at least in part, to the previously overlooked effect of tricuspid regurgitation on patient outcomes. The development of edge-to-edge repair represents the forefront of innovations in transcatheter procedures. There is a scarcity of data about tricuspid annuloplasty and replacement, and further study is necessary. Transcatheter mitral, tricuspid, and pulmonary procedures show prospects for the future, while their role in clinical practice has not been definitively established.
No takes yet. Share an insight, caveat, or question.
Ktenopoulos et al. (2024) conducted a review in Valvular Heart Disease (Mitral, Tricuspid, and Pulmonary). Transcatheter therapies (edge-to-edge repair, replacement, annuloplasty) was evaluated. Transcatheter mitral, tricuspid, and pulmonary procedures provide novel therapeutic alternatives for high-risk patients, though their definitive role in clinical practice is still being established.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: